All In Biotech

Drug Trial Radar · NCT07577843

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease

A Phase 3, Randomized, Double-blind, and Active-controlled Multicenter Study to Evaluate the Efficacy and Safety of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease

Last checked: Nov 20, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 460 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

460

Planned (sponsor's estimate)

Start

May 22, 2026

Primary completion

Jun 12, 2028

Study completion Jul 12, 2030

Sponsor

Lead sponsor
Janssen Research & Development, LLCJohnson & Johnson (Janssen) (JNJ)
Sponsor type
Industry
First posted
May 11, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to assess how well JNJ-78934804 works (efficacy) and how safe it is (safety) as compared to guselkumab at Week 48 in participants with moderately to severely active Crohn's disease (a long-term, progressive \[worsens with time\] and life-threatening disease of the intestine).

Conditions

  • Crohn Disease

Interventions

  • JNJ-78934804Drug

    JNJ-78934804 will be administered subcutaneously.

  • GuselkumabDrug

    Guselkumab will be administered subcutaneously.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Co-Primary: Percentage of Participants with Clinical Remission at Week 48Time frame: At Week 48
  2. Co-Primary: Percentage of Participants with Endoscopic Remission at Week 48Time frame: At Week 48

Locations

287 sites in 30 countries. Site status is shown where the registry gives one.

  • Mayo Clinic

    Scottsdale, Arizona · Recruiting

  • GIA Sun City

    Sun City, Arizona · Recruiting

  • Clinnova Research

    Anaheim, California · Recruiting

  • Gastro SB Clinic

    Chula Vista, California · Recruiting

  • United Medical Doctors

    Los Alamitos, California · Recruiting

  • Medical Associates Research Group, Inc.

    San Diego, California · Recruiting

  • Peak Gastroenterology Associates

    Colorado Springs, Colorado · Recruiting

  • Florida Research Center Inc.

    Lakewood Rch, Florida · Recruiting

  • Sanchez Clinical Research, Inc

    Miami, Florida · Recruiting

  • Endoscopic Research Inc

    Orlando, Florida · Recruiting

  • GCP Clinical Research

    Tampa, Florida · Recruiting

  • Atlanta Gastroenterology Specialists

    Suwanee, Georgia · Recruiting

  • Tri-State Gastroenterology Assoc

    Crestview Hills, Kentucky · Recruiting

  • Gastroenterology Clinic of Acadiana

    Lafayette, Louisiana · Recruiting

  • GIA Metairie

    Metairie, Louisiana · Recruiting

  • GIA Kansas City

    Lee's Summit, Missouri · Recruiting

  • New York Gastroenterology Associates

    New York, New York · Recruiting

  • GIA Rochester

    Rochester, New York · Recruiting

  • University of North Carolina Hospital

    Chapel Hill, North Carolina · Recruiting

  • Great Lakes Gastroenterology Research, LLC

    Mentor, Ohio · Recruiting

  • Digestive Disease Specialists Inc

    Oklahoma City, Oklahoma · Recruiting

  • The Oregon Clinic

    Portland, Oregon · Recruiting

  • Michigan Center of Medical Research

    Farmington Hill, Pennsylvania · Recruiting

  • Palmetto Primary and Specialty Care Physicians, Charleston

    Summerville, South Carolina · Recruiting

  • Gastro One

    Cordova, Tennessee · Recruiting

  • Tyler Research Institute, LLC

    Tyler, Texas · Recruiting

  • GIA Webster

    Webster, Texas · Recruiting

  • GIA Richmond

    Richmond, Virginia · Recruiting

  • GI Alliance Tacoma

    Tacoma, Washington · Recruiting

  • Sanatorio Duarte Quiroz

    Córdoba, Argentina · Recruiting

  • GEDYT

    Famailla, Argentina · Recruiting

  • Globalpsy

    La Plata, Argentina · Recruiting

  • HIGEA

    Mendoza, Argentina · Recruiting

  • Cer Instituto Medico

    Quilmes, Argentina · Recruiting

  • Hospital Provincial del Centenario

    Rosario, Argentina · Recruiting

  • Banksia Trials SA

    Adelaide, Australia · Recruiting

  • Royal Prince Alfred Hospital

    Camperdown, Australia · Recruiting

  • Monash Medical Centre

    Clayton, Australia · Recruiting

  • SA Gastrointestinal Services IBD SA

    Kurraba Point, Australia · Recruiting

  • Macquarie University

    Macquarie Island, Australia · Recruiting

Showing 40 of 287 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.